APA

Hughes Z. A., Neal S. J., Smith D. L., Sukoff Rizzo S. J., Pulicicchio C. M., Lotarski S., Lu S., Dwyer J. M., Brennan J., Olsen M., Bender C. N., Kouranova E., Andree T. H., Harrison J. E., Whiteside G. T., Springer D., O'Neil S. V., Leonard S. K., Schechter L. E., Dunlop J., Rosenzweig-Lipson S. & Ring R. H. (20130702). Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. : Neuropharmacology.

Chicago

Hughes Z A, Neal S J, Smith D L, Sukoff Rizzo S J, Pulicicchio C M, Lotarski S, Lu S, Dwyer J M, Brennan J, Olsen M, Bender C N, Kouranova E, Andree T H, Harrison J E, Whiteside G T, Springer D, O'Neil S V, Leonard S K, Schechter L E, Dunlop J, Rosenzweig-Lipson S and Ring R H. 20130702. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. : Neuropharmacology.

Harvard

Hughes Z. A., Neal S. J., Smith D. L., Sukoff Rizzo S. J., Pulicicchio C. M., Lotarski S., Lu S., Dwyer J. M., Brennan J., Olsen M., Bender C. N., Kouranova E., Andree T. H., Harrison J. E., Whiteside G. T., Springer D., O'Neil S. V., Leonard S. K., Schechter L. E., Dunlop J., Rosenzweig-Lipson S. and Ring R. H. (20130702). Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. : Neuropharmacology.

MLA

Hughes Z A, Neal S J, Smith D L, Sukoff Rizzo S J, Pulicicchio C M, Lotarski S, Lu S, Dwyer J M, Brennan J, Olsen M, Bender C N, Kouranova E, Andree T H, Harrison J E, Whiteside G T, Springer D, O'Neil S V, Leonard S K, Schechter L E, Dunlop J, Rosenzweig-Lipson S and Ring R H. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. : Neuropharmacology. 20130702.